Tomlinson JW - Search Results

1

11beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes.

Morgan SA, Tomlinson JW. Morgan SA, et al. Among authors: tomlinson jw. Expert Opin Investig Drugs. 2010 Sep;19(9):1067-76. doi: 10.1517/13543784.2010.504713. Expert Opin Investig Drugs. 2010. PMID: 20707593 Review.

2

The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.

Tomlinson JW, Bujalska I, Stewart PM, Cooper MS. Tomlinson JW, et al. Endocr Res. 2000 Nov;26(4):711-22. doi: 10.3109/07435800009048591. Endocr Res. 2000. PMID: 11196447

3

Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines.

Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM. Tomlinson JW, et al. Endocrinology. 2001 May;142(5):1982-9. doi: 10.1210/endo.142.5.8168. Endocrinology. 2001. PMID: 11316764

4

Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.

Tomlinson JW, Stewart PM. Tomlinson JW, et al. Best Pract Res Clin Endocrinol Metab. 2001 Mar;15(1):61-78. doi: 10.1053/beem.2000.0119. Best Pract Res Clin Endocrinol Metab. 2001. PMID: 11469811 Review.

5

Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.

Stewart PM, Toogood AA, Tomlinson JW. Stewart PM, et al. Among authors: tomlinson jw. Horm Res. 2001;56 Suppl 1:1-6. doi: 10.1159/000048126. Horm Res. 2001. PMID: 11786677 Review.

6

Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.

Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM. Tomlinson JW, et al. J Clin Endocrinol Metab. 2002 Dec;87(12):5630-5. doi: 10.1210/jc.2002-020687. J Clin Endocrinol Metab. 2002. PMID: 12466364

7

11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol.

Bujalska IJ, Walker EA, Tomlinson JW, Hewison M, Stewart PM. Bujalska IJ, et al. Among authors: tomlinson jw. Endocr Res. 2002 Nov;28(4):449-61. doi: 10.1081/erc-120016822. Endocr Res. 2002. PMID: 12530648

8

The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.

Tomlinson JW, Stewart PM. Tomlinson JW, et al. Horm Metab Res. 2002 Nov-Dec;34(11-12):746-51. doi: 10.1055/s-2002-38242. Horm Metab Res. 2002. PMID: 12660893 Review.

9

Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.

Tomlinson JW, Crabtree N, Clark PM, Holder G, Toogood AA, Shackleton CH, Stewart PM. Tomlinson JW, et al. J Clin Endocrinol Metab. 2003 May;88(5):2113-8. doi: 10.1210/jc.2002-021894. J Clin Endocrinol Metab. 2003. PMID: 12727963 Clinical Trial.

10

Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.

Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I, Malunowicz E, White PC, Hewison M, Mason PJ, Connell JM, Shackleton CH, Stewart PM. Draper N, et al. Among authors: tomlinson jw. Nat Genet. 2003 Aug;34(4):434-9. doi: 10.1038/ng1214. Nat Genet. 2003. PMID: 12858176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page